Inhibitors | Comment | Organism | Structure |
---|---|---|---|
3-((3r,5r,7r)-adamantan-1-yl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine | isozyme 11beta-HSD1 IC50: 74 nM, isozyme 11beta-HSD2 IC50: 0.004 mM | Homo sapiens | |
3-((3r,5r,7r)-adamantan-1-yl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine | isozyme 11beta-HSD1 IC50: 74 nM, isozyme 11beta-HSD2 IC50: 0.004 mM | Mus musculus | |
3-(3,4,7-trimethyltricyclo[3.3.1.13,7]dec-1-yl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine | isozyme 11beta-HSD1 IC50: 180 nM, isozyme 11beta-HSD2 IC50: 0.004 mM | Homo sapiens | |
3-(3,4,7-trimethyltricyclo[3.3.1.13,7]dec-1-yl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine | isozyme 11beta-HSD1 IC50: 180 nM, isozyme 11beta-HSD2 IC50: 0.004 mM | Mus musculus | |
3-(3,4-dimethyltricyclo[3.3.1.13,7]dec-1-yl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine | isozyme 11beta-HSD1 IC50: 13 nM, isozyme 11beta-HSD2 IC50: 0.00255 mM | Homo sapiens | |
3-(3,4-dimethyltricyclo[3.3.1.13,7]dec-1-yl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine | isozyme 11beta-HSD1 IC50: 13 nM, isozyme 11beta-HSD2 IC50: 0.00255 mM | Mus musculus | |
3-(3,5,7-trimethyladamantyl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine | IC50: 118 nM, 11betaHSD1; IC50: above 4000 nM, 11betaHSD2 | Mus musculus | |
3-(3,5-dimethyladamantyl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine | IC50: 104 nM, 11betaHSD1; IC50: above 10000 nM, 11betaHSD2 | Mus musculus | |
3-(3,5-dimethyladamantyl)methyl-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine | IC50: 50 nM, 11betaHSD1; IC50: above 4000 nM, 11betaHSD2 | Mus musculus | |
3-(3,5-dimethyladamantylmethyl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine | isozyme 11beta-HSD1 IC50: 36 nM, isozyme 11beta-HSD2 IC50: 0.0176 mM | Homo sapiens | |
3-(3,5-dimethyladamantylmethyl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine | isozyme 11beta-HSD1 IC50: 36 nM, isozyme 11beta-HSD2 IC50: 0.0176 mM | Mus musculus | |
3-(3-bromoadamantyl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine | IC50: 292 nM, 11betaHSD1; IC50: above 4000 nM, 11betaHSD2 | Mus musculus | |
3-(3-bromotricyclo[3.3.1.13,7]dec-1-yl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine | isozyme 11beta-HSD1 IC50: 23 nM, isozyme 11beta-HSD2 IC50: 0.004 mM | Homo sapiens | |
3-(3-bromotricyclo[3.3.1.13,7]dec-1-yl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine | isozyme 11beta-HSD1 IC50: 23 nM, isozyme 11beta-HSD2 IC50: 0.004 mM | Mus musculus | |
3-(3-fluoroadamantyl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine | IC50: 417 nM, 11betaHSD1; IC50: above 4000 nM, 11betaHSD2 | Mus musculus | |
3-(3-fluorotricyclo[3.3.1.13,7]dec-1-yl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine | isozyme 11beta-HSD1 IC50: 37 nM, isozyme 11beta-HSD2 IC50: 0.004 mM | Homo sapiens | |
3-(3-fluorotricyclo[3.3.1.13,7]dec-1-yl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine | isozyme 11beta-HSD1 IC50: 37 nM, isozyme 11beta-HSD2 IC50: 0.004 mM | Mus musculus | |
3-(3-hydroxyadamantyl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine | IC50: 1674 nM, 11betaHSD1; IC50: above 4000 nM, 11betaHSD2 | Mus musculus | |
3-(3-phenyladamantyl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine | IC50: 365 nM, 11betaHSD1; IC50: above 4000 nM, 11betaHSD2 | Mus musculus | |
3-(3-phenyltricyclo[3.3.1.13,7]dec-1-yl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine | isozyme 11beta-HSD1 IC50: 2.3 nM, isozyme 11beta-HSD2 IC50: 23 nM | Homo sapiens | |
3-(3-phenyltricyclo[3.3.1.13,7]dec-1-yl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine | isozyme 11beta-HSD1 IC50: 2.3 nM, isozyme 11beta-HSD2 IC50: 23 nM | Mus musculus | |
3-(6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-3-yl)tricyclo[3.3.1.13,7]decan-1-ol | isozyme 11beta-HSD1 IC50: 739 nM, isozyme 11beta-HSD2 IC50: 0.004 mM | Homo sapiens | |
3-(6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-3-yl)tricyclo[3.3.1.13,7]decan-1-ol | isozyme 11beta-HSD1 IC50: 739 nM, isozyme 11beta-HSD2 IC50: 0.004 mM | Mus musculus | |
3-(adamantan-1-yl)-5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridine | isozyme 11beta-HSD1 IC50: 7.8 nM, isozyme 11beta-HSD2 IC50: above 0.003 mM | Homo sapiens | |
3-(adamantan-1-yl)-5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridine | isozyme 11beta-HSD1 IC50: 98 nM, isozyme 11beta-HSD2 IC50: above 0.01 mM | Mus musculus | |
3-(tricyclo[3.3.1.13,7]dec-1-yl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine | isozyme 11beta-HSD1 IC50: 7.7 nM, isozyme 11beta-HSD2 IC50: 0.004 mM | Homo sapiens | |
3-(tricyclo[3.3.1.13,7]dec-1-yl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine | isozyme 11beta-HSD1 IC50: 7.7 nM, isozyme 11beta-HSD2 IC50: 0.004 mM | Mus musculus | |
3-adamant-2-yl-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine | IC50: 35 nM, 11betaHSD1; IC50: above 4000 nM, 11betaHSD2 | Mus musculus | |
3-adamantyl-5,6,7,8,9,10,11,12,13,14-decahydro[1,2,4]triazolo[4,3-a]azacyclododecine | IC50: 9.2 nM, 11betaHSD1; IC50: above 4000 nM, 11betaHSD2 | Mus musculus | |
3-adamantyl-5,6,7,8,9,10,11,12-octahydro[1,2,4]triazolo[4,3-a]azecine | IC50: 4.6 nM, 11betaHSD1; IC50: about 4000 nM, 11betaHSD2 | Mus musculus | |
3-adamantyl-5,6,7,8,9,10-hexahydro[1,2,4]triazolo[4,3-a]azocine | IC50: 16 nM, 11betaHSD1; IC50: about 10000 nM, 11betaHSD2 | Mus musculus | |
3-adamantyl-5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridine | IC50: 1112 nM, 11betaHSD1; IC50: above 10000 nM, 11betaHSD2 | Mus musculus | |
3-adamantyl-6,7,8,9,10,11,12,13-octahydro-5H-[1,2,4]triazolo[4,3-a]azacycloundecine | IC50: 11650 nM, 11betaHSD2; IC50: 2.2 nM, 11betaHSD1 | Mus musculus | |
3-adamantyl-6,7,8,9,10,11-hexahydro-5H-[1,2,4]triazolo[4,3-a]azonine | IC50: 4563 nM, 11betaHSD2; IC50: 8 nM, 11betaHSD1 | Mus musculus | |
3-adamantyl-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine | IC50: 98 nM, 11betaHSD1; IC50: above 4000 nM, 11betaHSD2 | Mus musculus | |
3-adamantyl-6,7-dihydro-5H-pyrrolo[2,1-c][1,2,4]triazole | IC50: 10000 nM, 11betaHSD2; IC50: 6820 nM, 11betaHSD1 | Mus musculus | |
3-adamantylmethy-5,6,7,8,9,10-hexahydro[1,2,4]triazolo[4,3-a]azocine | IC50: 587 nM, 11betaHSD1; IC50: above 4000 nM, 11betaHSD2 | Mus musculus | |
5-adamantyl-3-benzyl-4-methyl-4H-1,2,4-triazole | IC50: 14 nM, 11betaHSD1; IC50: above 4000 nM, 11betaHSD2 | Mus musculus | |
5-adamantyl-3-butyl-4-methyl-4H-1,2,4-triazole | IC50: 91 nM, 11betaHSD1; IC50: above 4000 nM, 11betaHSD2 | Mus musculus | |
5-adamantyl-3-ethyl-4-propyl-4H-1,2,4-triazole | IC50: 23 nM, 11betaHSD1; IC50: 50 nM, 11betaHSD2 | Mus musculus | |
5-adamantyl-3-methyl-4-butyl-4H-1,2,4-triazole | IC50: 270 nM, 11betaHSD1; IC50: above 4000 nM, 11betaHSD2 | Mus musculus | |
5-adamantyl-3-phenyl-4-methyl-4H-1,2,4-triazole | IC50: 109 nM, 11betaHSD1; IC50: above 4000 nM, 11betaHSD2 | Mus musculus | |
5-adamantyl-3-propyl-4-ethyl-4H-1,2,4-triazole | IC50: 50 nM, 11betaHSD1; IC50: above 4000 nM, 11betaHSD2 | Mus musculus | |
adamantyl triazoles | eight derivatives of different ring size, IC50 of 1.4-2180 nM for isozyme 11beta-HSD1, and of 8.7-2000 nM for isozyme 11beta-HSD2, the IC50 value decreases with increasing ring size, overview | Homo sapiens | |
adamantyl triazoles | eight derivatives of different ring size, IC50 of 1.4-2180 nM for isozyme 11beta-HSD1, and of 8.7-2000 nM for isozyme 11beta-HSD2, the IC50 value decreases with increasing ring size, overview | Mus musculus | |
n-alkyl-substituted adamantyl triazoles | substituted with methyl to butyl groups, IC50: of 3-72 nM for isozyme 11beta-HSD1, and of about 0.004 mM for isozyme 11beta-HSD2, overview | Homo sapiens | |
n-alkyl-substituted adamantyl triazoles | substituted with methyl to butyl groups, IC50: of 3-72 nM for isozyme 11beta-HSD1, and of about 0.004 mM for isozyme 11beta-HSD2, overview | Mus musculus |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
endoplasmic reticulum | associated, isozyme 11beta-HSD1 | Homo sapiens | 5783 | - |
endoplasmic reticulum | associated, isozyme 11beta-HSD1 | Mus musculus | 5783 | - |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
cortisol + NAD+ | Mus musculus | isozyme 11beta-HSD2 catalyzes the reverse reaction with cofactor NAD+ | cortisone + NADH | - |
ir | |
cortisone + NADPH + H+ | Homo sapiens | isozyme 11beta-HSD1 catalyzes the forward reaction with cofactor NADPH | cortisol + NADP+ | - |
ir | |
cortisone + NADPH + H+ | Mus musculus | isozyme 11beta-HSD1 catalyzes the forward reaction with cofactor NADPH | cortisol + NADP+ | - |
ir |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
isozymes 11beta-HSD1 and 11beta-HSD2 | - |
Mus musculus | P50172 | isozymes 11beta-HSD1 and 11beta-HSD2 | - |
Mus musculus | P50172 | isozyme 11beta-HSD1; isozyme 11beta-HSD1 | - |
Mus musculus | P51661 | isozyme 11beta-HSD2; isozyme 11beta-HSD2 | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
cortisol + NAD+ | isozyme 11beta-HSD2 catalyzes the reverse reaction with cofactor NAD+ | Mus musculus | cortisone + NADH | - |
ir | |
cortisone + NADPH + H+ | isozyme 11beta-HSD1 catalyzes the forward reaction with cofactor NADPH | Homo sapiens | cortisol + NADP+ | - |
ir | |
cortisone + NADPH + H+ | isozyme 11beta-HSD1 catalyzes the forward reaction with cofactor NADPH | Mus musculus | cortisol + NADP+ | - |
ir |
Synonyms | Comment | Organism |
---|---|---|
11beta-HSD1 | - |
Homo sapiens |
11beta-HSD1 | - |
Mus musculus |
11beta-HSD2 | - |
Mus musculus |
11beta-hydroxysteroid dehydrogenase type 1 | - |
Homo sapiens |
11beta-hydroxysteroid dehydrogenase type 1 | - |
Mus musculus |
11beta-hydroxysteroid dehydrogenase type 2 | - |
Mus musculus |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
NAD+ | 11beta-HSD2 | Mus musculus | |
NADPH | 11beta-HSD1 | Mus musculus |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.0000022 | - |
IC50: 2.2 nM, 11betaHSD1 | Mus musculus | 3-adamantyl-6,7,8,9,10,11,12,13-octahydro-5H-[1,2,4]triazolo[4,3-a]azacycloundecine | |
0.0000046 | - |
IC50: 4.6 nM, 11betaHSD1 | Mus musculus | 3-adamantyl-5,6,7,8,9,10,11,12-octahydro[1,2,4]triazolo[4,3-a]azecine | |
0.000008 | - |
IC50: 8 nM, 11betaHSD1 | Mus musculus | 3-adamantyl-6,7,8,9,10,11-hexahydro-5H-[1,2,4]triazolo[4,3-a]azonine | |
0.0000092 | - |
IC50: 9.2 nM, 11betaHSD1 | Mus musculus | 3-adamantyl-5,6,7,8,9,10,11,12,13,14-decahydro[1,2,4]triazolo[4,3-a]azacyclododecine | |
0.000014 | - |
IC50: 14 nM, 11betaHSD1 | Mus musculus | 5-adamantyl-3-benzyl-4-methyl-4H-1,2,4-triazole | |
0.000016 | - |
IC50: 16 nM, 11betaHSD1 | Mus musculus | 3-adamantyl-5,6,7,8,9,10-hexahydro[1,2,4]triazolo[4,3-a]azocine | |
0.000023 | - |
IC50: 23 nM, 11betaHSD1 | Mus musculus | 5-adamantyl-3-ethyl-4-propyl-4H-1,2,4-triazole | |
0.000035 | - |
IC50: 35 nM, 11betaHSD1 | Mus musculus | 3-adamant-2-yl-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine | |
0.00005 | - |
IC50: 50 nM, 11betaHSD1 | Mus musculus | 3-(3,5-dimethyladamantyl)methyl-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine | |
0.00005 | - |
IC50: 50 nM, 11betaHSD1 | Mus musculus | 5-adamantyl-3-propyl-4-ethyl-4H-1,2,4-triazole | |
0.00005 | - |
IC50: 50 nM, 11betaHSD2 | Mus musculus | 5-adamantyl-3-ethyl-4-propyl-4H-1,2,4-triazole | |
0.000091 | - |
IC50: 91 nM, 11betaHSD1 | Mus musculus | 5-adamantyl-3-butyl-4-methyl-4H-1,2,4-triazole | |
0.000098 | - |
IC50: 98 nM, 11betaHSD1 | Mus musculus | 3-adamantyl-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine | |
0.000104 | - |
IC50: 104 nM, 11betaHSD1 | Mus musculus | 3-(3,5-dimethyladamantyl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine | |
0.000109 | - |
IC50: 109 nM, 11betaHSD1 | Mus musculus | 5-adamantyl-3-phenyl-4-methyl-4H-1,2,4-triazole | |
0.000118 | - |
IC50: 118 nM, 11betaHSD1 | Mus musculus | 3-(3,5,7-trimethyladamantyl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine | |
0.00027 | - |
IC50: 270 nM, 11betaHSD1 | Mus musculus | 5-adamantyl-3-methyl-4-butyl-4H-1,2,4-triazole | |
0.000292 | - |
IC50: 292 nM, 11betaHSD1 | Mus musculus | 3-(3-bromoadamantyl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine | |
0.000365 | - |
IC50: 365 nM, 11betaHSD1 | Mus musculus | 3-(3-phenyladamantyl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine | |
0.000417 | - |
IC50: 417 nM, 11betaHSD1 | Mus musculus | 3-(3-fluoroadamantyl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine | |
0.000587 | - |
IC50: 587 nM, 11betaHSD1 | Mus musculus | 3-adamantylmethy-5,6,7,8,9,10-hexahydro[1,2,4]triazolo[4,3-a]azocine | |
0.001112 | - |
IC50: 1112 nM, 11betaHSD1 | Mus musculus | 3-adamantyl-5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridine | |
0.001674 | - |
IC50: 1674 nM, 11betaHSD1 | Mus musculus | 3-(3-hydroxyadamantyl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine | |
0.004 | - |
IC50: about 4000 nM, 11betaHSD2 | Mus musculus | 3-adamantyl-5,6,7,8,9,10,11,12-octahydro[1,2,4]triazolo[4,3-a]azecine | |
0.004 | - |
IC50: above 4000 nM, 11betaHSD2 | Mus musculus | 3-adamantyl-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine | |
0.004 | - |
IC50: above 4000 nM, 11betaHSD2 | Mus musculus | 3-adamantyl-5,6,7,8,9,10,11,12,13,14-decahydro[1,2,4]triazolo[4,3-a]azacyclododecine | |
0.004 | - |
IC50: above 4000 nM, 11betaHSD2 | Mus musculus | 3-adamant-2-yl-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine | |
0.004 | - |
IC50: above 4000 nM, 11betaHSD2 | Mus musculus | 3-(3,5,7-trimethyladamantyl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine | |
0.004 | - |
IC50: above 4000 nM, 11betaHSD2 | Mus musculus | 3-(3-phenyladamantyl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine | |
0.004 | - |
IC50: above 4000 nM, 11betaHSD2 | Mus musculus | 3-(3-bromoadamantyl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine | |
0.004 | - |
IC50: above 4000 nM, 11betaHSD2 | Mus musculus | 3-(3-hydroxyadamantyl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine | |
0.004 | - |
IC50: above 4000 nM, 11betaHSD2 | Mus musculus | 3-(3-fluoroadamantyl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine | |
0.004 | - |
IC50: above 4000 nM, 11betaHSD2 | Mus musculus | 3-adamantylmethy-5,6,7,8,9,10-hexahydro[1,2,4]triazolo[4,3-a]azocine | |
0.004 | - |
IC50: above 4000 nM, 11betaHSD2 | Mus musculus | 3-(3,5-dimethyladamantyl)methyl-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine | |
0.004 | - |
IC50: above 4000 nM, 11betaHSD2 | Mus musculus | 5-adamantyl-3-butyl-4-methyl-4H-1,2,4-triazole | |
0.004 | - |
IC50: above 4000 nM, 11betaHSD2 | Mus musculus | 5-adamantyl-3-propyl-4-ethyl-4H-1,2,4-triazole | |
0.004 | - |
IC50: above 4000 nM, 11betaHSD2 | Mus musculus | 5-adamantyl-3-methyl-4-butyl-4H-1,2,4-triazole | |
0.004 | - |
IC50: above 4000 nM, 11betaHSD2 | Mus musculus | 5-adamantyl-3-benzyl-4-methyl-4H-1,2,4-triazole | |
0.004 | - |
IC50: above 4000 nM, 11betaHSD2 | Mus musculus | 5-adamantyl-3-phenyl-4-methyl-4H-1,2,4-triazole | |
0.004563 | - |
IC50: 4563 nM, 11betaHSD2 | Mus musculus | 3-adamantyl-6,7,8,9,10,11-hexahydro-5H-[1,2,4]triazolo[4,3-a]azonine | |
0.00682 | - |
IC50: 6820 nM, 11betaHSD1 | Mus musculus | 3-adamantyl-6,7-dihydro-5H-pyrrolo[2,1-c][1,2,4]triazole | |
0.01 | - |
IC50: 10000 nM, 11betaHSD2 | Mus musculus | 3-adamantyl-6,7-dihydro-5H-pyrrolo[2,1-c][1,2,4]triazole | |
0.01 | - |
IC50: about 10000 nM, 11betaHSD2 | Mus musculus | 3-adamantyl-5,6,7,8,9,10-hexahydro[1,2,4]triazolo[4,3-a]azocine | |
0.01 | - |
IC50: above 10000 nM, 11betaHSD2 | Mus musculus | 3-adamantyl-5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridine | |
0.01 | - |
IC50: above 10000 nM, 11betaHSD2 | Mus musculus | 3-(3,5-dimethyladamantyl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine | |
0.01165 | - |
IC50: 11650 nM, 11betaHSD2 | Mus musculus | 3-adamantyl-6,7,8,9,10,11,12,13-octahydro-5H-[1,2,4]triazolo[4,3-a]azacycloundecine |